Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisements of the Extract of Un-Audited Financial Results for the quarter ended 31.12.2022 and year to date from 01.04.2022 to 31.12.2022 approved in Board Meeting of the Company held on 10.02.2023 Genomic Valley Biotech Ltd - 539206 - Appointment Of Internal Auditors Of The Company
Appointment of Internal Auditors of the Company Genomic Valley Biotech Ltd - 539206 - Intimation Of Appointments
Intimation of Appointments Genomic Valley Biotech Ltd - 539206 - Un-Audited Financial Results For The Quarter Ended 31.12.2022 And Year To Date From 01.04.2022 To 31.12. 2022
Un-Audited Financial Results for the quarter ended 31.12.2022 and year to date from 01.04.2022 to 31.12. 2022 Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Outcomes Of Board Meeting And Un-Audited Financial Results For The Quarter Ended 31.12.2022 And Year To Date From 01.04.2022 To 31.12. 2022
Outcomes of Board Meeting and Un-Audited Financial Results for the quarter ended 31.12.2022 and year to date from 01.04.2022 to 31.12. 2022 Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisements published for the Notice of Board Meeting to be held on 10th February, 2023, inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2022, in the newspapers, Financial Express (English Edition) and Jansatta (Hindi Edition) on 03rd February, 2023 Genomic Valley Biotech Ltd - 539206 - Closure of Trading Window
In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday, the 10th February, 2023 at 11:45 A.M. inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2022. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st January, 2023 till 48 hours of declaration of results i.e. 12th February, 2023 (both days inclusive). Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December, 2022
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 ,inter alia, to consider and approve the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2022 Genomic Valley Biotech Ltd - 539206 - Signed Minutes Of Annual General Meeting Held On 30.12.2022
Signed Minutes of Annual General Meeting held on 30.12.2022 Genomic Valley Biotech Ltd - 539206 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate pursuant to Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended on 31st December, 2022